Skip to main content

Prevent Academics Raiding Small Business R&D Funds (2025)

Preventing academics from “raiding” small business R&D funds in Australia requires tight governance over R&D contracting, clear ownership of IP and deliverab...

accounting, prevent, academics, from, raiding, small, business, r&d, funds

15/12/202517 min read

Prevent Academics Raiding Small Business R&D Funds (2025)

Professional Accounting Practice Analysis
Topic: Prevent academics from raiding small business R&D funds

Last reviewed: 18/12/2025

Focus: Accounting Practice Analysis

Prevent Academics Raiding Small Business R&D Funds (2025)

Preventing academics from “raiding” small business R&D funds in Australia requires tight governance over R&D contracting, clear ownership of IP and deliverables, robust evidence for the R&D Tax Incentive (RDTI), and payment controls that link funding to measurable outputs—because the RDTI is designed to support eligible R&D activities conducted by (or for) the claimant company, not to subsidise poorly controlled university spend. From an Australian accounting practice perspective, the solution is not simply “better contracts”; it is an integrated control framework that aligns Corporations Act director duties, ATO substantiation expectations, and AusIndustry’s R&D activity eligibility rules, so funds cannot be diverted into academic overheads, unrelated research agendas, or non-eligible activities while still being claimed as “R&D”.

What does “academics raiding small business R&D funds” mean in practice?

It generally means R&D budgets intended to produce a commercial product outcome are consumed by costs that primarily benefit the academic institution rather than the SME’s eligible R&D activities and commercialisation pathway.

Common patterns seen in Australian SME engagements include:

  • Excessive “overhead” or “on-cost” loading without clear value or deliverables
  • Scope drift into curiosity-led research, publications, or student projects not aligned to the SME’s hypothesis and technical uncertainty
  • Delays combined with continued billing (time-and-materials with weak governance)
  • Ambiguous IP terms that leave the SME paying for work yet unable to commercialise
  • Poor documentation (no experiment logs, test results, design iterations), increasing risk in an AusIndustry/ATO review

From an accounting/tax standpoint, the core risk is that the spend becomes ineligible or unsupported, leading to RDTI adjustments, repayment, penalties and interest, and potential director governance issues.

Why is this a governance and tax risk for Australian SMEs?

It is a governance risk because directors must ensure company funds are used for proper corporate purposes and with due care and diligence. It is a tax risk because R&D claims must align with the legislative framework and withstand integrity checks.

Key Australian compliance anchors that must be considered:

  • Income Tax Assessment Act 1997 (ITAA 1997), Division 355: Governs the R&D Tax Incentive (noting that detailed application depends on facts and the annual guidance).
  • Industry Research and Development Act 1986 (IR&D Act): Underpins the registration and compliance regime administered by AusIndustry (Department of Industry, Science and Resources).
  • ATO guidance on the R&D Tax Incentive: The ATO sets expectations on record keeping, nexus between expenditure and eligible activities, and integrity of claims.
  • AusIndustry R&D eligibility guidance: Focuses on “core R&D activities” and “supporting R&D activities”, including requirements around experimentation and technical uncertainty.

Practical point for accountants: when university invoices are broad (“research services”, “project support”), the evidentiary burden becomes difficult. That is exactly where “raiding” happens—money leaves the SME, while the SME cannot prove the spend was incurred on eligible R&D activities with the required experimentation and purpose.

How do the R&D Tax Incentive rules make SMEs vulnerable to “fund leakage”?

SMEs become vulnerable when they assume that “work done by a university” automatically equals “eligible R&D”, or that an academic’s credibility replaces documentation.

High-risk misconceptions include:

  • “If the university is involved, it must be R&D.”
  • “A literature review is R&D.”
  • “A prototype build is automatically core R&D.”
  • “General lab time is fine—records don’t need to be granular.”

Eligibility is fact-driven. In practice, AusIndustry focuses on whether you conducted systematic experimentation to resolve technical uncertainty. The ATO then expects your expenditure to have a defensible nexus to those eligible activities and to be substantiated.

What “fund leakage” looks like in RDTI terms:

  • University bills include non-eligible components (administration, teaching, publication time, conference travel) that SMEs attempt to claim as R&D expenditure.
  • Activities are described as “research” but lack experimental method or relate to market research, routine testing, or quality control.
  • IP terms prevent the SME from using results, undermining the commercial rationale and “for whom” the R&D was conducted.

What contract structures stop academics from diverting SME R&D funds?

The most effective prevention mechanism is to convert an open-ended academic collaboration into controlled contract R&D with enforceable deliverables.

What should the engagement structure be?

It should be structured so the SME controls:

  • Scope
  • Budget
  • Deliverables
  • Acceptance criteria
  • IP and confidentiality
  • Reporting cadence and evidence standards
  • Rights to terminate and step-in

Practical contract controls (accountant-friendly checklist):

  • Milestone-based payments:
  • Deliverables must be auditable:
  • Scope boundaries:
  • IP provisions (foreground IP):
  • Background IP disclosures:
  • Change control:
  • No “bundled overhead” without transparency:

What payment terms reduce “budget drain”?

  • Retainage: Hold back a percentage until final acceptance.
  • Invoice detail requirements: Names, hours, tasks, dates, and mapped deliverables.
  • Hard caps: Maximum billable hours per role per milestone.
  • Termination for convenience: SME can exit if deliverables aren’t met, preserving funds.

How should SMEs control R&D cash flow so money cannot be “raided”?

The strongest approach is to treat R&D like a controlled project, not a “relationship”.

Recommended financial controls for Australian SMEs:

  • Separate R&D cost centres and project codes:
  • Purchase order (PO) controls:
  • Three-way matching:
  • Monthly variance review:
  • Board-level oversight for material R&D spend:

Accounting practice tip: if you cannot explain an invoice line item in plain English and map it to a specific experiment or test, it is high risk for RDTI defensibility.

What records are required so the ATO and AusIndustry can’t deny the claim?

To prevent leakage and protect the claim, records must demonstrate both eligibility (AusIndustry focus) and expenditure nexus/substantiation (ATO focus).

What evidence should you demand from academics each month?

  • Experiment plans: hypothesis, variables, methodology, acceptance criteria
  • Experiment logs: what was done, by whom, when, what changed, results
  • Test outputs: raw data, analysis, failures, re-tests, iteration notes
  • Version control: code commits, CAD versioning, dataset versioning
  • Meeting minutes: decisions, technical blockers, next steps
  • Timesheets mapped to tasks: not generic “research hours”

What should be avoided because it is commonly attacked in reviews?

  • Broad descriptions like “research assistance”
  • Pure literature reviews (may be supporting at best, often non-eligible depending on purpose and nexus)
  • Publications and conference activity (often non-eligible and/or difficult to justify)
  • Student projects where SME does not control deliverables and IP

It should be noted that ATO and AusIndustry reviews frequently focus on whether claims are “reconstructed after the fact.” Contemporaneous records are materially more defensible.

How can accountants design “anti-raiding” controls without killing collaboration?

The best controls are operationally light but evidence-heavy: they preserve academic freedom inside a defined box.

A workable model is:

  1. SME defines the technical uncertainty and commercial objective.
  2. Academic team executes experiments inside that framework.
  3. Payment is released only when evidence is delivered.
  4. IP and confidentiality are non-negotiable.

A practical example (real-world scenario):

  • An Australian medtech SME engages a university lab to test a novel biomaterial coating.
  • Without controls: the lab pivots into side experiments for publication, bills extra “lab development”, and delivers only a high-level report.
  • With controls: the SME requires a test matrix, raw data delivery, and predefined performance metrics; invoices are capped per milestone; foreground IP is assigned to the SME.
  • Result: the SME can substantiate the R&D narrative, demonstrate systematic experimentation, and defend the expenditure allocation.

How do you compare MyLedger-style controls vs Xero/MYOB workflows for R&D spend tracking?

Preventing R&D fund leakage is materially easier when the bookkeeping system supports tight categorisation, evidence attachment, and rapid exception review—because “raiding” is usually detected in exceptions, not in totals.

Key workflow comparison for Australian practices managing R&D-heavy clients:

  • Reconciliation speed (exception handling):
  • Automation of coding patterns (recurring academic invoices, overhead splits, eligible vs non-eligible mapping):
  • Working paper readiness (audit trail for claims):
  • ATO-integrated compliance context:

Accounting practice implication: when R&D claims are on the line, time saved in reconciliation is not just labour efficiency—it is governance. Fast close + better evidence capture reduces the window where leakage goes unnoticed.

What clauses and controls should be non-negotiable in university R&D agreements?

Non-negotiables are those that prevent value extraction without deliverables.

Minimum non-negotiable positions:

  • Milestones and acceptance criteria: deliverables must be objective and testable
  • Foreground IP assignment or exclusive commercial licence: aligned to SME commercialisation
  • Confidentiality and publication controls: publication requires SME approval and timing controls (to protect patentability and trade secrets)
  • Full cost transparency: line-item invoices; pre-approved rates; no hidden overhead
  • Right to audit project records: including lab logs, timesheets, and deliverables
  • Termination and step-in rights: SME can transition work to another provider if delivery fails
  • Data delivery obligation: raw data and working files must be delivered, not just summaries

How should SMEs respond if they suspect funds are being diverted?

The correct response is to act early, document decisions, and preserve evidentiary integrity.

Recommended steps:

  1. Freeze discretionary spend: pause non-critical invoices pending review.
  2. Request substantiation pack: deliverables, timesheets, experiment logs, and data.
  3. Run an eligibility mapping review: map each work package to core/supporting/non-R&D.
  4. Renegotiate to milestones and caps: convert time-and-materials to deliverable-based.
  5. Escalate governance: board minute the issue and remediation plan.
  6. RDTI risk assessment: consider whether previous expenditure needs reclassification before registration/claim finalisation.

If fraud is suspected, legal advice should be obtained promptly.

Next Steps: How Fedix can help protect R&D budgets

Fedix supports Australian accounting practices and SMEs by reducing the manual burden that allows R&D spend leakage to hide in reconciliations and spreadsheets.

Practical ways Fedix and MyLedger help:

  • Automated bank reconciliation: AutoRecon reduces close time by up to 90% (10–15 minutes vs 3–4 hours), making exceptions (like unexpected university overhead charges) visible sooner.
  • AI-powered categorisation: consistent coding of eligible vs non-eligible R&D spend, improving month-to-month discipline.
  • Automated working paper outputs: reduces reliance on manual Excel packs that are often rebuilt under time pressure during RDTI reviews.
  • ATO-integrated workflows: keeps compliance context centralised for practice teams managing multiple obligations.

Learn more at home.fedix.ai and consider implementing an “R&D spend control pack” for clients engaging universities in the 2025–2026 tax year.

Conclusion

Preventing academics from raiding small business R&D funds is achieved through enforceable milestone contracting, IP control, evidence-driven governance, and disciplined accounting treatment aligned to Australian R&D Tax Incentive requirements. Where SMEs fail, it is usually because they outsource control along with the work—leaving weak substantiation, scope drift, and non-eligible costs embedded in invoices. Australian accounting practices should implement a standardised control framework that makes every R&D dollar traceable to an eligible activity and a delivered output.

Disclaimer: This information is general in nature and does not constitute legal or tax advice. Tax laws and ATO/AusIndustry guidance are complex and subject to change. Advice should be obtained from a qualified tax professional and legal adviser for your specific circumstances.

Frequently Asked Questions

Q: Is it illegal for a university to charge overheads to an SME R&D project?

Overheads are not inherently illegal, but they must be contractually agreed, transparent, and deliver value. From an R&D Tax Incentive perspective, the critical issue is whether the expenditure is properly substantiated and sufficiently connected to eligible R&D activities as required under the governing legislation and ATO expectations.

Q: Can SMEs claim the R&D Tax Incentive for work done by academics?

Yes, SMEs can potentially claim eligible R&D expenditure for contracted activities, provided the activities meet AusIndustry eligibility requirements and the expenditure is substantiated and appropriately apportioned. Documentation and clear contractual control over deliverables materially improve defensibility.

Q: What is the single most effective way to stop “R&D fund leakage” to academics?

Milestone-based contracting with objective deliverables and payment holds is the most effective single control. It forces evidence production, limits scope drift, and prevents continued billing without measurable progress.

Q: What records should we keep to satisfy ATO/AusIndustry reviews?

You should retain contemporaneous experiment plans, logs, test results, raw data, version histories, meeting minutes, and detailed invoices/timesheets mapped to tasks. Records should make it clear what technical uncertainty was addressed and how systematic experimentation was conducted.

Q: How can an accounting firm operationalise these controls across many SME clients?

Standardise an “R&D governance pack” including engagement templates, monthly evidence checklists, and consistent chart-of-accounts mapping for eligible vs non-eligible spend. Using automation platforms like MyLedger can reduce reconciliation time and improve consistency of coding and working paper outputs across the practice.